TY  - JOUR 
AU  - Barriocanal Casado, Eliana
AU  - Hidalgo Gutiérrez, Agustín
AU  - Raimundo, Nuno
AU  - González García, Pilar
AU  - Acuña Castroviejo, Darío
AU  - Escames Rosa, Germaine
AU  - López García, Luis Carlos
PY  - 2019
UR  - http://hdl.handle.net/10481/56472
AB  - Background: The vastmajority ofmitochondrial disorders have limited the clinicalmanagement to palliative care.
Rapamycin has emerged as a potential therapeutic drug formitochondrial diseases since it has shown therapeutic
benefits in a...
LA  - eng
PB  - Elsevier B. V.
KW  - CoQ deficiency
KW  - Mitochondrial encephalopathy
KW  - Mitochondrial diseases
KW  - mTORC1
KW  - Mouse model
TI  - Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease
DO  - https://doi.org/10.1016/j.ebiom.2019.03.025
ER  -